ASX 200 Insider Trades: Directors bought and sold these 7 stocks last week

About this update from Ebos Group Limited

Welcome back to the Insider Trades series – a weekly summary of on-market ASX 200 director transactions valued at more than $10,000. The below trades have all taken place between 3 and 9 October 2025. Directors have up to 5 business days to notify the ASX of their trades.Top ASX 200 Insider BuysCodeCompanyDateDirectorPriceValueEBOEbos Group 7/10/25Julie Tay$26.00$52,000SHLSonic Healthcare 3/10/25Katharine Giles$21.72$21,720ORAOrora 6/10/25Thomas Gorman$2.06$10,300Interesting takeawaysEbos Group has attracted buying interest from another non-executive director following a 14.6% selloff on the day of its FY25 result (27 August). While the results broadly met expectations, FY26 EBITDA guidance of 3% growth was below Macquarie expectations of 8%. The stock has since fallen to its lowest level since early 2021. However, Citi analysts noted on 18 September that "consensus has also seen downward revisions to estimates, which we think are now probably done. Expected market growth in the various subsegments of healthcare still looks somewhat opaque, but we think, if anything, there is potentially some room for upside into FY26/27, especially if Animal Care (5% of revenue but more of EBITDA) outperforms."Sonic Healthcare has similarly seen directors step in to buy the dip, with six separate insiders collectively purchasing around $525,000 worth of shares in recent weeks. The catalyst was a weak FY25 result on 21 August, with NPAT 3% below expectations, pathology EBITDA margin 60 bps under consensus at 17.7%, and FY26 guidance also missing forecasts. This triggered a 12.8% one-day selloff, followed by a further 14.5% decline since. While Citi analysts acknowledged "some bright spots in the print with double-digit CER growth in the UK and the radiology division, both of which we expect to remain strong," they remained cautious on US revenue growth (the company's second-largest market) after a disappointing FY25 relative to larger peers. In their 18 September note, they maintained a Neutral rating with a $24.00 target price.Top ASX 200 Insider SellsCodeCompanyDateDirectorPriceValueWTCWisetech Global 9/10/25Richard White$87.16$50,008,050GDGGeneration Development Group 8/10/25Robert Coombe$7.15$2,003,123NWHNRW Holdings 8/10/25Michael Arnett$4.73$945,381PRUPerseus Mining 9/10/25Elissa Cornelius$4.96$620,000PRUPerseus Mining 9/10/25Elissa Cornelius$4.96$520,800Interesting...

View stock analysis, news, and events for Ebos Group Limited